Adenovirus EIA gene products are capable of modulating the expression of a variety of integrated genes. To study the mechanisms by which this regulation occurs, recombinant retroviruses have been utilized to establish cell lines containing an integrated copy of either the adenovirus E2 or E3 promoter adjacent to the bacterial guanine phosphoribosyl transferase (GPT) gene. These cell lines have been characterized with respect to both basal and ElA-induced levels of GPT gene expression. Cell lines with low levels of GPT gene expression showed increased expression in the presence of ElA, whereas cell lines with high basal levels of GPT gene expression had decreased GPT RNA levels in the presence of EIA. Further characterization of these cell lines revealed ElA modulation of the accumulation of RNA initiating at a retrovirus promoter adjacent to the E2 or E3 promoter. The use of the GPT gene as a marker of E2 or E3 promoter activity has allowed the isolation of cell lines which have spontaneously increased their levels of GPT RNA. A preliminary characterization of four of these cell lines has indicated that GPT gene expression is increased as a result of cis activation of the E2 promoter.
The adenovirus type 5 ElA region encodes three overlapping mRNAs derived by differential splicing to generate 13S, 12S, and 9S transcripts (2, 28) . These mRNAs encode polypeptides which are responsible for a broad range of biological functions. The largest polypeptide, 289 amino acids in size, is responsible for the transactivation of other adenovirus early promoters and is essential for the expression of the fully transformed phenotype during adenovirusinduced oncogenesis (1, 15, 21, 24, 25, 29, 31) . The 243-amino-acid polypeptide is also necessary for adenovirusinduced oncogenesis and appears to be efficient at increasing the growth potential of certain types of primary cells in tissue culture (5, 13, 19, [24] [25] [26] . The smallest polypeptide is 55 amino acids long, and its role in the viral life cycle has yet to be elucidated.
The ElA-encoded polypeptides have also been shown to modulate the expression of a variety of cellular genes. For example, in HeLa cells, expression of the 70-kilodalton heat shock protein and ,-tubulin genes is increased in the presence of ElA (27, 33) . In contrast, ElA expression in lymphoid cells diminishes the steady-state level of immunoglobulin heavy-chain mRNA (11) . Similarly, insulin gene expression in pancreatic cell lines and fibronectin and collagen gene expression in fibroblast cell lines are diminished in the presence of ElA (30, 34) . Since ElA has profound effects on both the expression of specific cellular genes and the regulation of cell growth, many laboratories have attempted to define the relationship between these activities by utilizing ElA mutants. These studies have demonstrated that the same ElA domains are involved in both the repression of specific promoters and the establishment of the transformed phenotype (20, 25, 26, 38) .
To further characterize the transcriptional regulatory activity of ElA, the effects of ElA-encoded polypeptides on the expression of various cellular and viral genetic units have been studied. Generally, these experiments have been undertaken by the cotransfection of plasmids containing ElA and the gene to be studied; after 24 to 48 h, the modulation * Corresponding author.
of target gene expression is assayed (3, 9, 10, 12, 14, 16, 17, 35) . The results of these experiments have indicated that ElA can increase transcription of transfected genes lacking enhancers while repressing the transcription of some genes containing enhancers. Although these assays have provided considerable information about the transcriptional modulating activity of ElA, they do not address the role of ElA in the modulation of the expression of integrated genes.
In this report, we describe studies on the expression of a stably integrated promoter whose transcription is modulated by ElA. We have chosen to study the adenovirus E2 and E3 promoters, since the expression of these promoters during the viral life cycle is enhanced by ElA. These promoters retain ElA responsiveness when stably integrated into host cell chromosomes (8) , and their expression is also modulated by the specific gene products of other viruses (32, 36) . A series of cell lines containing a single copy of the E2 or E3 promoter directing the expression of a selectable marker gene has been established by using retrovirus-mediated gene transfer. To study the effects of ElA on the stably integrated promoters, these cell lines were infected with recombinant retroviruses containing ElA cDNAs. These studies demonstrated that the nature of the ElA effect depends on the basal level of expression of the E2 or E3 promoter. In addition, the effects of ElA on promoters adjacent to the E2 or E3 promoter were studied. Fig. 1 ). This vector lacks the 5' retroviral splice site, allowing initiation from internal promoters (18 renders the cell resistant to histidinol. pANeo is a recombinant retrovirus vector containing a deletion of the enhancer in the 3' LTR, a deleted 5' splice site, and the actin promoter directing expression of the TnS neo gene (B. C. Guild, M. Fiener, D. Houseman, and R. C. Mulligan, submitted for publication). pHISBglII was a gift from J. Morgan and R. C. Mulligan, and pANeo was a gift from B. Guild and R. C. Mulligan. The adenovirus E2 and E3 promoters were isolated from the HindIll H fragment of the adenovirus 5 genome. The E2 promoter was a 325-base-pair EcoRISau3Al fragment, and the E3 promoter was a 300-base-pair EcoRI-Sau3Al fragment. These promoters were ligated to the BglII site at the 5' end of the guanine phosphoribosyl transferase (GPT) gene and inserted into the BglII site of a pHISBglII plasmid from which the SV40 promoter had been deleted. The E2 promoter was also inserted into pANeo from which the actin promoter was deleted. To generate recombinant retroviruses, 10 jLg of plasmid DNA was transfected into t42 cells (23) by calcium phosphate precipitation, and culture medium was harvested 20 h later (6, 7, 30) .
MATERIALS AND METHODS

Materials
Establishment of cell lines. All cell lines were grown in Dulbecco modified Eagle medium with 10% calf serum and penicillin-streptomycin. Recombinant retroviruses derived from plasmids containing the E2 or E3 promoter-GPT gene inserted into pHISBglII were used to infect NIH 3T3 cells. Cells were infected as described previously (6, 30) , and 48 h after infection, cells were split at a ratio of 1:40 into medium containing 2.5 mM histidinol (Sigma Chemical Co., St. Louis, Mo. (Fig. 1 ). These retroviruses lack the retroviral 5' splice site, allowing the generation of transcripts initiating at internal promoters (18) . These (Fig. 2, row A) . Analysis of ElA effects on stably ihtegrated E2 or E3 promoters. To determine if stably integrated E2 or E3 promoters were subject to modulation by ElA, the six representative cell lines were infected with another recombinant retrovirus containing the cDNA encoding the ElA 289-amino-acid polypeptide. In this recombinant retrovirus, expression of the ElA cDNA is promoted by the viral 5' LTR, whereas the adjacent TnS neo gene, encoding G418 resistance, is controlled by an SV40 promoter (Fig. 1D) . To prepare populations of the six cell lines stably expressing the ElA 289-amino-acid polypeptide, each cell line was infected with this recombinant retrovirus and selected in G418. RNA was prepared from each of these populations and analyzed for GPT RNA sequences (Fig. 2, row B) . Parental cell lines containing low levels of GPT RNA (Fig. 2, lanes 1, 3, and 6) demonstrated increases of GPT RNA in the presence of the 289-amino-acid polypeptide, whereas parental cell lines with high levels of GPT RNA (lanes 2 and 5) showed decreases in GPT RNA. (20 ,ug) was electrophoresed in a formaldehyde agarose gel, transferred to nitrocellulose, and hybridized to 32p_ labeled GPT DNA as described in Materials and Methods. Lane 1, RNA prepared from cell line 1 (Fig. 2) ; lane 2, RNA prepared from cell line 1 after infection with the recombinant retrovirus depicted in Fig. 1D . Values to the right of the gels are molecular sizes (in kilobases). aa, Amino acid. l the steady-state level of GPT RNA which of these transcripts were modulated by ElA expreshis response is related to the basal sion, RNA was prepared from cell line 1 (Fig. 2, lane 1) , from promoter. In a similar analysis of 40 populations of cell line 1 expressing the ElA 289-amino-acid results were obtained regardless of polypeptide, and from populations of cell line 1 infected with ntained the E2 or the E3 promoter.
a recombinant retrovirus without an ElA cDNA insert. This Llines contained high levels of GPT RNA was fractionated by formaldehyde agarose electrophoin the presence of the ElA 289-resis, transferred to nitrocellulose, and hybridized to radioCell lines generated by infection of actively labeled GPT tDNA. Cell line 1 contained a single combinant retrovirus containing an detectable transcript corresponding in size to that of a adjacent to the GPT gene failed to full-length viral RNA (Fig. 3A, lane 1) . Populations of this GPT RNA levels in the presence of cell line expressing the ElA 289-amino-acid polypeptide polypeptide (data not shown).
showed a marked increase in the amount of full-length viral recombinant retrovirus used to gentranscript and the appearance of a second major transcript of ;tates that GPT RNA sequences are the size expected for an RNA initiated at the internal E2 ing transcripts, a full-length retrovipromoter (Fig. 3A, (Fig. 1B) . Cell lines 5 adenovirus promoter was either deleted or replaced by an asing the recombinant retrovirus contain-SV40 promoter were prepared. These retroviruses were er (Fig. 1C) Fig. 1D. the presence or absence of the EIA 289-amino-acid polypeptide, as described above. The structure of the retroviral constructs used and the result of the analysis of RNA levels are shown in Fig. 4 . Four cell lines containing retroviral integrants with an internal SV40 promoter and two cell lines containing integrants lacking an internal promoter showed no detectable modulation of the levels of viral RNA. We therefore conclude that the accumulation of full-length retrovirus transcripts concomitant with EIA expression requires the presence of an internal E2 promoter.
In an additional series of experiments, the activity of the other ElA-encoded polypeptides in the modulation of the stably integrated E2 or E3 promoter was tested. For these studies, the starting cell line containing the E3 promoter-GPT sequences was cell line 6 (Fig. 2, lane 6) . Populations of cells expressing the ElA 289-, 243-, or 55-amino-acid polypeptide were generated by infection of cell line 6 with recombinant retroviruses containing the corresponding EIA cDNA. RNA was prepared from the starting cell line and each of the populations was analyzed as described above (Fig. 5) . It is apparent that only the population of cells expressing the 289-amino-acid polypeptide (lane 2) had markedly increased levels of GPT RNA. We conclude that, at least for this cell line, the ability to increase levels of GPT transcripts is a function of the 289-amino-acid polypeptide but not of the 243-or the 55-amino-acid polypeptide. In this respect, the regulation of the E3 promoter seen in this cell line is similar to that seen in the course of an adenovirus infection.
Functional retroviral enhancer not required for EIA activation of E2 promoter. To determine whether a functional retroviral enhancer was necessary for ElA activation of a stably integrated E2 promoter, we utilized retroviral vectors containing a deletion of the 3' enhancer sequence. The recombinant retrovirus derived from these vectors results in a stable integrant lacking enhancer sequences in each LTR (7, 37) . Such a vector containing an internal E2 promoter adjacent to the Tn5 neo gene was used to prepare a recombinant retrovirus stock. Viral titers were then determined for the production of G418-resistant colonies on either NIH 3T3 FIG. 5 . RNA (20 .Lg) from cell line 6 (Fig. 2) and enhancer-deleted E2-G418, enhancer-deleted recombinant retroviruses containing the actin promoter and the E2 promoter adjacent to the Tn5 )7Co gene, respectively. Cell line 3T3 13S constitutively expresses the ElA 289-amino-acid polypeptide and was produced as described in Materials and Methods. Cell line 3T3 HIS is a control cell line produced as described in Materials aind Methods. Preparations of recombinant retroviruses were dilu.ted and used to infect the indicated cell lines. After 14 days of selection in G418, plates were stained with crystal violet and the colony number was counted. Dol virus was hairvested from a high-titer producer cell line stably producing virus (7, 18, 23) . The other two virus preparations were obtained as descrilbed in Materials and Methods.
Viral titer is reported as the number of colonies produced by infection of the indicated cell line with 1 ml of the virus preparation.
J. VIROL. noted with the E2 promoter was most likely due to increased expression of the G418 resistance gene induced by the ElA polypeptide and that the retroviral promoter is not necessary for this induction. In cells infected with this virus, there was predominantly one transcript which corresponded in size to a transcript initiating at the E2 promoter (Fig. 6 ). In this experiment, a transcript initiating at the 5' LTR would be expected to produce a 3.6-kilobase RNA.
Growth of cell lines in GPT-selective medium. Cell lines containing the E2 or E3 promoter adjacent to the GPT gene were further analyzed for their growth in GPT-selective medium. Cell lines with high basal levels of GPT RNA, as exemplified by cell line 2 (Fig. 2) survived GPT selection in the presence or absence of the ElA 289-amino-acid polypeptide. In contrast, cell lines with low basal levels of GPT RNA showed an increment in colony number concomitant with ElA expression. In the analysis of 40 such cell lines, this increment was largest for cell line 1 (Fig. 1) , which formed colonies at a frequency of 10-5 in the absence of ElA and 10-2 in the presence of ElA (Fig. 7) . The rare colonies generated in the absence of ElA posed a number of interesting questions, one of which was whether the requirement for ElA induction had been replaced by an analogous cellular function. To address this question, we infected cells Fig. 2) and cell line 1 infected with the recombinant retrovirus depicted in Fig. 1D and selected in G418 were analyzed for growth in GPT-selective medium. Cells (5 x 104) were plated in GPT-selective medium, the medium was changed every 3 days, and the tissue culture plates were stained with crystal violet at 14 days. The plate on the left contains cell line 1, and the plate on the right contains cell line 1 infected with a recombinant retrovirus expressing the ElA 289-amino-acid (289aa) polypeptide cDNA. " Enhancer-deleted E2-G418 retrovirus is described in Table 1 , footnote a. The viral titer was determined and reported as described in Table 1 , footnotes a and b, respectively. Cell line 3T3 13S is described in Materials and Methods and in Table 1 , footnote a. Cell lines Rl, R2, R3, and R4 are derivatives of cell line 1 (Fig. 2) obtained by growing cell line 1 in GPT-selective medium.
from these colonies with a retrovirus containing the E2 promoter directing the expression of the G418 resistance gene. As described above, this retrovirus showed a higher frequency of G418-resistant colony formation on cells expressing ElA function. However, such an increase in colony formation was not seen when this recombinant retrovirus was used to infect these spontaneously arising GPT-resistant cell lines (Table 2 ). These data indicate that these cells do not express an ElA-like function capable of activating the E2 promoter. Since a preliminary characterization of these cell lines has revealed an increase in GPT RNA (data not shown), we suspect that they may arise due to an alteration in the nucleic acid structure adjacent to the GPT gene. This hypothesis is currently under investigation.
DISCUSSION
This report describes the use of recombinant retroviruses to establish cell lines containing a stably integrated copy of the adenovirus E2 or E3 promoter initiating transcription of the GPT gene. Characterization of these cell lines demonstrated wide variations in the basal levels of these transcripts. Since infections with retroviral recombinants under the conditions employed here result in the integration of a single proviral sequence (6, 30) , these variations are most likely related to the site of proviral integration into the host chromosome. Our observations also correlated this variation in basal activity with the nature of the ElA effect seen. Cell lines having low basal levels of expression demonstrated increased levels of transcripts in the presence of ElA, while cell lines having high levels of expression showed a reduction in the amounts of these RNAs. Many factors have been shown to influence the mode of action of the ElA polypeptides on gene expression; these factors include the nature of the target promoter (3, 11, 14, 16) , the presence or absence of adjacent enhancer sequences (3) , and the cell type (4 globin promoter that accumulates RNA initiating at both the 5' LTR and an internal globin promoter in a differentiationspecific manner (7) . However, in their studies, accumulation of RNA initiating at the 5' LTR did not depend upon the presence of an internal globin promoter, whereas in the present studies, the accumulation of transcripts originating in the 5' LTR depended upon the presence of the internal E2 promoter. The requirement for the E2 promoter for increased levels of transcripts initiating at the LTR promoter could be the result of several effects of EMA: (i) the ElA activation of the E2 promoter could induce a local change in chromosomal structure that activates both the target and adjacent promoters, and (ii) the presence of the E2 sequences may interfere with the generation of full-length transcripts initiating at the LTR; ElA may then induce changes at the E2 promoter which facilitate the accumulation of full-length transcripts initiating at the LTR. Experiments which directly assess transcription from these promoters and which measure the ability of ElA to regulate the accumulation of cellular transcripts originating in sites adjacent to the integration sites of the recombinant retrovirus may help to distinguish between these models.
As discussed above, several of the cell lines studied showed marked increases in GPT mRNA in the presence of ElA. An analysis of these cell lines to determine whether the increase in GPT mRNA was sufficient to allow cells to survive GPT selection revealed a relative growth advantage for cells expressing ElA. We suspect that a more complete dependence on ElA for survival in GPT-selective medium could not be demonstrated because the most marked increments in GPT mRNA in response to ElA occurred for the cell lines with the lowest basal levels. In these cell lines, the amounts of GPT mRNA in the presence of ElA were still relatively low and apparently not sufficient to allow the efficient growth of cells in GPT-selective medium. Additional cell lines have been established by infection with an enhancer-deleted retrovirus containing the E2 promoter adjacent to the Tn5 neo gene. Preliminary studies demonstrated that some of these cell lines only grow in G418-selective medium when the ElA 289-amino-acid polypeptide is present. Such cell lines can be used to isolate and characterize cellular genes encoding functions that activate the E2 promoter. This approach also allows the identification of cells within a clonal cell line that spontaneously develop the capacity to grow in selective media in the absence of a transactivating polypeptide. The study of these variant cells will be of value in determining the stability of genes integrated into the host chromosome and in defining those changes that lead to autonomy from specific transactivating functions.
The characterization of the cell lines described in this report has provided preliminary information regarding the regulation of integrated E2 and E3 promoters. This use of selectable markers may prove useful in the analysis of other promoters. For example, recombinant retroviruses containing promoter mutations may help define sequences necessary for the optimum expression of the integrated promoter in various cell types. Similarly, the importance of specific sequences in the response to extracellular influences, such as hormone induction, can be studied. This application of retrovirus-mediated transfer has the following advantages: (i) the ability to efficiently transfer the promoter of interest, (ii) the ability to establish cell lines containing a single integrant, (iii) the ability to use a selectable marker adjacent to the promoter of interest to allow the study of rare events altering promoter function, and (iv) the ability to use stable cell lines to study parameters altering promoter function.
